Leading CDMO adopts Veeva Vault QMS, Vault
QualityDocs, and Vault Training to standardize quality processes
and manage GxP content across its organization
PLEASANTON, Calif., Dec. 19,
2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today
announced that Recipharm, a global contract development and
manufacturing organization (CDMO), will use Veeva Vault QMS, Veeva
Vault QualityDocs, and Veeva Vault Training to streamline its
quality operations. Veeva quality applications will help Recipharm
achieve greater quality oversight, use resources more effectively,
accelerate validation, and maintain inspection readiness.
"Harmonizing quality processes and GxP documentation across
Recipharm sites will make our quality operations more efficient and
scalable," said Vanessa Nardolillo,
head of quality management and regulatory affairs at Recipharm.
"With Veeva Vault Quality, Recipharm is setting a new global
standard for quality management, site collaboration, and
compliance. The system will enable us to provide our customers with
a standard approach to quality. It forms a key part of our focus on
continuous improvement, to unleash excellence in quality across our
services."
Recipharm offers manufacturing services to pharmaceutical and
medical device companies. Vault QMS will help Recipharm gain
greater control and visibility into quality processes, with Vault
QualityDocs, driving efficient GxP content management and
information sharing among sites. With Vault Training, Recipharm can
deploy learning content and curricula to help ensure its GxP
effectiveness and compliance.
"Unifying quality processes, content, and training on Veeva
Vault Quality will help Recipharm keep contract development and
manufacturing on track as it continues to scale," said Rob Gaertner, vice president of quality strategy
for Europe at Veeva. "We're
excited to partner with Recipharm in evolving its quality
operations."
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-Q for the period ended October 31, 2023, which you can
find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/recipharm-harmonizes-its-global-quality-operations-with-veeva-vault-quality-302018697.html
SOURCE Veeva Systems